Advertisement
Singapore markets open in 2 hours 16 minutes
  • Straits Times Index

    3,322.62
    +14.72 (+0.45%)
     
  • S&P 500

    5,267.84
    -39.17 (-0.74%)
     
  • Dow

    39,065.26
    -605.78 (-1.53%)
     
  • Nasdaq

    16,736.03
    -65.51 (-0.39%)
     
  • Bitcoin USD

    67,598.72
    -1,549.48 (-2.24%)
     
  • CMC Crypto 200

    1,466.73
    -35.94 (-2.39%)
     
  • FTSE 100

    8,339.23
    -31.10 (-0.37%)
     
  • Gold

    2,333.10
    -4.10 (-0.18%)
     
  • Crude Oil

    76.91
    +0.04 (+0.05%)
     
  • 10-Yr Bond

    4.4750
    +0.0410 (+0.92%)
     
  • Nikkei

    39,103.22
    +486.12 (+1.26%)
     
  • Hang Seng

    18,868.71
    -326.89 (-1.70%)
     
  • FTSE Bursa Malaysia

    1,629.18
    +7.09 (+0.44%)
     
  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     
  • PSE Index

    6,659.99
    +52.77 (+0.80%)
     

Global Bovine Respiratory Disease Treatment Strategic Business Report 2024-2030 Featuring Bayer, Bimeda, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Merck, Vetoquinol, Virbac, & Zoetis

Company Logo
Company Logo

Bovine Respiratory Disease Treatment Market

Bovine Respiratory Disease Treatment Market
Bovine Respiratory Disease Treatment Market

Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Bovine Respiratory Disease Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global Bovine Respiratory Disease Treatment Market to Reach $3.4 Billion by 2030

The global market for Bovine Respiratory Disease Treatment estimated at US$2.2 Billion in the year 2023, is projected to reach a revised size of US$3.4 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Vaccines, one of the segments analyzed in the report, is expected to record 6.8% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Antibiotics segment is estimated at 5.7% CAGR for the next 8-year period.



The U.S. Market is Estimated at $578.1 Million, While China is Forecast to Grow at 8.4% CAGR

The Bovine Respiratory Disease Treatment market in the U.S. is estimated at US$578.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$808.1 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 5.1% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Key Attributes:

Report Attribute

Details

No. of Pages

179

Forecast Period

2023 - 2030

Estimated Market Value (USD) in 2023

$2.2 Billion

Forecasted Market Value (USD) by 2030

$3.4 Billion

Compound Annual Growth Rate

5.6%

Regions Covered

Global



MARKET OVERVIEW

ADVERTISEMENT
  • Influencer Market Insights

  • World Market Trajectories

  • Bovine Respiratory Disease Treatment - Global Key Competitors Percentage Market Share in 2022 (E)

  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

  • Global Economic Update

FOCUS ON SELECT PLAYERS (Total 12 Featured)

  • Bayer AG

  • Bimeda Group

  • Boehringer Ingelheim International GmbH

  • Ceva Sante Animale

  • Elanco

  • Merck & Co., Inc.

  • Vetoquinol S.A.

  • Virbac Group

  • Zoetis Services LLC

For more information about this report visit https://www.researchandmarkets.com/r/ficepy

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900